Tumor detection with phase-contrast imaging: an evaluation of clinical potential.
- 1 January 1987
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 162 (1) , 199-203
- https://doi.org/10.1148/radiology.162.1.3786762
Abstract
The conspicuity of a variety of human tumors outside the liver, with a broad spectrum of histologic types, was evaluated using phase-contrast imaging (proton chemical shift imaging, proton spectroscopy) and the results compared with the data obtained using routine T1- and T2-weighted magnetic resonance (MR) imaging sequences. In all cases, tumors were most conspicuous using the phase-contrast technique. In two instances, the tumors could be discerned only by this method, being undetectable by any routine MR pulse sequence. The use of phase-contrast imaging is recommended as an adjunct to standard MR sequences when evaluating for either the presence or extent of a tumor, regardless of its anatomic location or histologic type.This publication has 8 references indexed in Scilit:
- Liver metastases: detection by phase-contrast MR imaging.Radiology, 1986
- Fatty infiltration of the liver: evaluation by proton spectroscopic imaging.Radiology, 1985
- Chemical shift imaging of bone marrow: preliminary experienceAmerican Journal of Roentgenology, 1985
- Detection of hepatic metastases by proton spectroscopic imaging. Work in progress.Radiology, 1985
- Proton chemical shift imaging: an evaluation of its clinical potential using an in vivo fatty liver model.Radiology, 1985
- Simple proton spectroscopic imaging.Radiology, 1984
- Nuclear magnetic resonance: in vivo proton chemical shift imaging. Work in progress.Radiology, 1983
- Nuclear Magnetic Resonance Relaxation and Water Contents in Normal Mouse and Rat Tissues and in Cancer Cells23JNCI Journal of the National Cancer Institute, 1980